Outcomes with autologous (Auto) and allogeneic (Allo) stem cell transplantation (SCT) for relapsed/refractory follicular lymphoma (FL) in the post-rituximab era: A comparative analysis from the National Comprehensive Cancer Network (NCCN) non-Hodgkin's lymphoma (NHL) outcomes database project Meeting Abstract


Authors: Evens, A. M.; Vanderplas, A.; LaCasce, A.; Crosby, A.; Nademanee, A.; Kaminski, M. S.; Abel, G. A.; Millenson, M.; Czuczman, M. S.; Rodriguez, M. A.; Niland, J.; Zelenetz, A. D.; Gordon, L. I.; Friedberg, J.
Abstract Title: Outcomes with autologous (Auto) and allogeneic (Allo) stem cell transplantation (SCT) for relapsed/refractory follicular lymphoma (FL) in the post-rituximab era: A comparative analysis from the National Comprehensive Cancer Network (NCCN) non-Hodgkin's lymphoma (NHL) outcomes database project
Meeting Title: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Journal Title: Blood
Volume: 118
Issue: 21
Meeting Dates: 2011 Dec 10-13
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2011-11-01
Start Page: 1756
End Page: 1757
Language: English
ACCESSION: WOS:000299597106280
PROVIDER: wos
DOI: 10.1182/blood.V118.21.4112.4112
Notes: --- - Meeting Abstract: 4112 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz